[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:ncf1-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"NCF1 Gene",2,1,[8,15],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06605378","Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease",[],"RECRUITING","2026-08-26T02:17:05.172421Z","2026-05-13T02:55:06.554315Z",{"nct_id":16,"title":17,"phases":18,"status":20,"updated_at":21,"content_modified":22},"NCT06559176","A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )",[19],"Phase 1\u002FPhase 2","ENROLLING_BY_INVITATION","2026-08-26T02:18:57.189473Z","2026-06-16T05:54:07.759857Z"]